(OTC: NFRM) Reaches Agreement With Globe Laboratories
March 04 2011 - 7:30AM
Marketwired
National Pharmaceuticals Corp (PINKSHEETS: NFRM) announced
yesterday that they have reached an agreement with Globe
Laboratories to become National's partner to develop its drugs
through the final stages.
By contacting with Globe Laboratories, National should see the
speed in which its drugs are approved expedited. With 1 in 10 drugs
not making final FDA approval,
(http://insidebioia.com/2011/02/15/release-of-biobiomedtracker-drug-approval-rates-study/)
companies like National need every advantage possible.
With many different aspects to focus on with getting a new drug
to market, using a company such as Globe ensures that it is in the
hands of an experienced team with a clear defined focus of their
role in National's next potential marketed drug.
For more information on National Pharmaceuticals recent news
release, please visit
http://finance.yahoo.com/news/National-Pharmaceuticals-Corp-iw-14165390.html?x=0&.v=1
Other active stocks are Pfizer Inc (NYSE: PFE), Bristol Myers
Squibb (NYSE: BMY) and 02 Secure Wireless (PINKSHEETS: OTOW)
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO News Wire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
Contact: Eric Jensen www.ionewswire.com 516.942.4910
O2 Secure Wireless (CE) (USOTC:OTOW)
Historical Stock Chart
From Jun 2024 to Jul 2024
O2 Secure Wireless (CE) (USOTC:OTOW)
Historical Stock Chart
From Jul 2023 to Jul 2024